A phase I dose-escalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors (Q39640343)
Jump to navigation
Jump to search
scientific article published on 15 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I dose-escalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors |
scientific article published on 15 March 2012 |
Statements
1 reference
A phase I dose-escalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors (English)
1 reference
Klaus Mross
1 reference
Annette Frost
1 reference
Simone Steinbild
1 reference
Susanne Hedbom
1 reference
Martin Büchert
1 reference
Ulrike Fasol
1 reference
Clemens Unger
1 reference
Jörn Krätzschmar
1 reference
Roland Heinig
1 reference
Oliver Boix
1 reference
Olaf Christensen
1 reference
15 March 2012
1 reference
1 reference
18
1 reference
9
1 reference
2658-2667
1 reference
Identifiers
1 reference
1 reference